PBRM1 and nonpapillary renal cell carcinoma: The frequency of PBRM1 mutation was similar between patients with aggressive and non-aggressive ccRCC, perhaps because it is an early, essential event in tumorigenesis that does not impact clinical outcome, but instead plays a principal role in tumor initiation.